Work

Reduced Dose Post-Transplant Cyclophosphamide in Allogeneic Hematopoietic Cell Transplant

Year: 2026

Type: article

Study design: Observational Study

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.jtct.2025.12.388

Authors: Lauren Scarpetti, Qiuhong Zhao, Daniel Ikeda, Jeremy Sen, Jooho Chung, Zachariah DeFilipp, Areej R. El-Jawahri, Steven L. McAfee, Richard Newcomb, Gregory Novak, Paul O'Donnell, Thomas R Spitzer, Sumithira Vasu, Gabriela Sanchez-Petitto, Nathan Denlinger, Jiasheng Wang, Marcos de Lima, Yi-Bin Chen, Hannah K. Choe

Institutions: Massachusetts General Hospital, The Ohio State University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Harvard University, The Ohio State University Wexner Medical Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7127300640

FWCI:

Cites:

Cited by:

Related to: 10